Handelsbanken assesses that Bravida's current valuation provides a sufficient buffer to withstand continued weak market conditions, highlighting that the installation business has historically demonstrated relative stability over time, with the potential to gradually return to normalized levels.

Coverage is initiated with a buy recommendation and a target price of 105 kronor. The bank emphasizes that the company has shown strong resilience in a weak market and has managed to protect its margins.

The forecast for the fourth quarter points to yet another quarter of negative organic growth, but the forward-looking valuation is considered attractive in anticipation of a gradual recovery during 2026 and 2027.